.avif)
Total amount raised
$1 Billion
Latest funding date
2026-07-15
Location
Neko Health has successfully raised funding over three rounds, with the latest being a $700 million Series C led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The company is backed by notable investors including Atomico, General Catalyst and Lakestar, and has raised $1.025 billion in total.
What Is Neko Health?
Neko Health, based in Stockholm, Sweden, is a pioneering company in the healthcare industry. Specializing in advanced scanning technology, the company focuses on preventive healthcare and early detection. Founded by a team of experts, Neko Health employs between 101 and 250 people.
Operating within the realms of Artificial Intelligence and healthcare, Neko Health has established health centers in London, Manchester, and Stockholm, and its first US clinics are opening in New York and other cities in 2026. The company is dedicated to improving healthcare outcomes and promoting regular health checks.
How Much Funding Has Neko Health Raised?
- Series A
- Amount Raised: $65,000,000
- Date: July 2023
- Lead Investors: Lakestar
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's initial growth and expansion efforts, as well as to invest in the development of their health diagnostics technology.
- Series B
- Amount Raised: $260,000,000
- Date: January 2025
- Lead Investors: Lightspeed Venture Partners
- Valuation at Round: $1.8 billion
- Motivation Behind the Round: To accelerate Neko Health's expansion plans within Europe and the US and to continue investing in research and development for new breakthrough health diagnostics.
- Series C
- Amount Raised: $700,000,000
- Date: July 15, 2026
- Lead Investors: Lightspeed Venture Partners, with O.G. Venture Partners as co-lead
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund Neko Health's US launch, starting with New York and further cities in 2026, alongside continued work on its body scan technology. Participants included Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD, Mark Zuckerberg, Priscilla Chan, Alexis Ohanian, Jimmy Iovine, Thierry Henry, Tim Ferriss and will.i.am.
Total Amount Raised: $1,025,000,000. Current Valuation: Not publicly disclosed, with the January 2025 Series B priced at $1.8 billion. As of September 2026, the company's latest disclosed round is its July 2026 Series C.
Key Investors
- Lightspeed Venture Partners
- Details: Lightspeed Venture Partners is a global venture capital firm that led Neko Health's Series B and Series C funding rounds. Bejul Somaia, a Global Partner at Lightspeed, joined Neko Health's Board of Directors.
- Investment Focus Areas: Technology, healthcare, innovative startups.
- Notable Investments: Snapchat, Affirm, Grubhub.
- General Catalyst
- Details: General Catalyst is a venture capital firm that participated in Neko Health's Series A, Series B and Series C funding rounds. The firm focuses on early-stage and growth-stage investments.
- Investment Focus Areas: Technology, healthcare.
- Notable Investments: Airbnb, Stripe, Warby Parker.
- O.G. Venture Partners
- Details: O.G. Venture Partners participated in Neko Health's Series B funding round and co-led the $700 million Series C in July 2026.
- Investment Focus Areas: Technology, healthcare startups.
- Notable Investments: Not publicly disclosed.
- Rosello
- Details: Rosello is a venture capital firm that participated in Neko Health's Series B funding round. The firm focuses on technology and healthcare innovations.
- Investment Focus Areas: Technology, healthcare innovations.
- Notable Investments: Not publicly disclosed.
- Lakestar
- Details: Lakestar led Neko Health's Series A and returned in both the Series B and the July 2026 Series C rounds. The firm focuses on technology, healthcare, and consumer internet.
- Investment Focus Areas: Technology, healthcare, consumer internet.
- Notable Investments: Spotify, Revolut, Opendoor.
What's Next for Neko Health?
With $700 million raised in its July 2026 Series C, Neko Health is opening its first US clinics, starting in New York and expanding to further cities during 2026. The company operates health centers in London, Manchester and Stockholm, and continues to invest in its body scan and diagnostics technology.
The Series C was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum and BDT & MSD, bringing total funding to $1.025 billion across three rounds.
Scaling into the US will require Neko Health to meet demand from its waiting list, navigate regulatory requirements in a new market, and maintain service quality as it adds clinics across more cities.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like Neko Health and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
